Testing Technologies for Central Nervous
System Disorders
Provista is currently developing two innovative, affordable types of tests to aid doctors and patients in the detection of one of the most debilitating CNS disorders facing our aging population: Alzheimer’s disease.
The REDx Test® and LymPro Test® are breakthrough blood test designed to work in conjunction with traditional diagnostic methods to help doctors develop a more timely and accurate diagnosis of dementia and its progression to Alzheimer’s disease.
Provista is dedicated to further research and development of test procedures into Central Nervous System (CNS) diseases, with a goal of improving the care and quality of life for people suffering from memory loss and cognitive impairment.